TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/18/2025
Back to search
Official data from USPTO
D DATAVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
12/19/2025
Trademark type
Combined
Nice classes
9, 35, 42
Filing date
12/13/2018
Registration date
04/07/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/07/2020
Last transaction
12/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
77
Owner location
US
Examiner
MARTINS, ODETTE
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized lowercase blue "D" inside of a blue hexagon which has a break at the top right. Above the stylized lowercase blue "D" are three blue squares. Below the hexagon image is the wording "DATAVANT" in black text. The mark is displayed on a white background which is not claimed as a feature of the mark.
Holders and representatives
Holders
Datavant, Inc.
Roivant Sciences GmbH
Representatives
Vanessa A. Ignacio, Esq. Lowenstein Sandler LLP
Technical classification
Nice Classes
Class 9Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for transmittinganalyzing and generating reports; downloadable Computer software for data processing in the field of healthcarebiomedical researchclinical trial data; Downloadable computer software for providinganalyzing and generating reports in the field of healthcarebiomedical researchclinical trial data; Downloadable computer software for data processing; Downloadable computer programs and computer operating systems for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and transmission of dataimages and information; Downloadable computer programs and computer operating systems for the conversionanalysisprocessingstorage and transmission of artificial intelligence; Downloadable artificial intelligence and machine learning software for statistical analysisconsultancy and reporting; Downloadable software for analytics in the field of public healthhealthcarepharmaceuticalsbiotechnologybiomedical research and developmentclinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Downloadable software for data linkagediscoveryde-identification used in the fields of healthcarebiomedical researchclinical trial data for the provision of medical servicespublic health services and healthcare services; Downloadable computer software for database integration; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software featuring an electronic computer database for linkingviewingde-identifying healthcare and healthcare related data used in the field of healthcarebiomedical researchclinical trial data; Downloadable computer software for accessing data and information related to healthcare servicespatient medical information and clinical trial data and for controlling and managing data and information related to healthcare servicespatient medical information and clinical trial data; none of the foregoing directly related to video surveillance or video based security apparatus
Class 35
Advertising; business management; business administration; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business data analysis and professional business consultancy services regarding statistics for biomedical researchhealthcare institutions and healthcare professionalsbased on artificial intelligence and machine learning; business analysis and statistical analysis of healthcare databiomedical research and clinical trial data; systematization and compilation of data in computer databases; compilation of information into computer databases for research and analysis purposes in the fields of public healthhealthcarebiomedicinebiotechnologypharmaceuticalsclinical trialspost-authorization research for the marketing of medicines and/or commercial post-launching of medicinesepidemiological researchpharmacoepidemiological research and research evaluating epidemiological outcomes; professional business analysisbusiness consultancy and statistical analysis for business purposes in the fields of public healthhealthcarepharmaceuticalsbiotechnologybiomedical research and developmentsclinical trialspost-authorization research for the marketing of medicines and/or commercial post-launching of medicinesepidemiological researchpharmacoepidemiological research and research evaluating epidemiological outcomes
Class 42
Scientific and technological servicesmedical research and scientific researchchemical analysis in the healthcare and biomedical field; Scientific research; Chemical analysis for industrial purposes; Biomedical research services; Design and development of computer software; Cloud computing featuring software for de-identifyinglinkinganalyzing data used in the field of healthcarebiomedical researchclinical trial data; Scientific data processing analysis services; Pharmaceutical and biomedical research servicesconducting clinical trials for otherspost-authorization research for the marketing of medicines and commercial post-launching of medicinesepidemiological researchpharmacoepidemiological research and research evaluating epidemiological outcomes; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifyinglinkinganalyzing data used in the field of healthcarebiomedical researchclinical trial data regarding analytics in the fields of public healthhealthcarepharmaceuticalsbiomedical research and clinical trial data; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifyinglinkinganalyzing data used in the field of healthcarebiomedical researchclinical trial data regarding information in the fields of public healthhealthcarepharmaceuticalsbiomedical research and clinical trials; Providing temporary use of non-downloadable software applications accessible via a web site for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and transmission of dataimages and information; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifyinglinkinganalyzing data used in the field of healthcarebiomedical researchclinical trial data regarding data in the fields of public healthhealthcarepharmaceuticalsbiomedical researchpatient dataclinical trialspost-authorization research for the marketing of medicines and/or commercial post-launching of medicinesepidemiological research and pharmacoepidemiological research; Providing technological online information in the fields of public healthhealthcarepharmaceuticalspatient databiomedical researchclinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific online information online in the fields of public healthhealthcarepharmaceuticalspatient databiomedical researchclinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific research information in the field of biomedicineclinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Scientific analysis in the field of scientific data relating to biomedical research and clinical trials; Research and analysis services in the scientific fields of artificial intelligence and machine learning analytics for biomedical research and healthcare institutions
Publications
History of USPTO decisions and trademark events.
56 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/18/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/18/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/18/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/15/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/07/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/29/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/14/2020
FIMP
FINAL DISPOSITION PROCESSED
08/14/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/21/2020
PUBO
PUBLISHED FOR OPPOSITION
01/21/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/17/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
12/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/13/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/13/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/13/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/13/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/03/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/03/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/03/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/03/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
11/13/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/13/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
11/13/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/13/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/31/2019
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
10/16/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/12/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/16/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/16/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/08/2019
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/26/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2019
RFNT
REFUSAL PROCESSED BY IB
06/28/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/27/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/03/2019
RFRR
REFUSAL PROCESSED BY MPU
06/03/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/12/2019
CNRT
NON-FINAL ACTION WRITTEN
05/11/2019
MAFR
APPLICATION FILING RECEIPT MAILED
05/07/2019
DOCK
ASSIGNED TO EXAMINER
05/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/02/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/18/2019
Continuous trademark protection
Get notified about every new filing that threatens D DATAVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.